White matter hyperintensities, the bright patches on MRI scans usually read as evidence of permanent damage to the brain's small blood vessels, do not always follow a one-way path. A longitudinal study from the Institut de Recerca Sant Pau, published in Alzheimer's & Dementia, tracked these lesions in people with Down syndrome and found that their burden can fluctuate over time and in some cases decrease - a pattern that was most apparent once the clinical symptoms of Alzheimer's disease had begun.
People with Down syndrome are among the most informative groups for Alzheimer's research because the protein changes that define the disease are present in nearly everyone by age 40. Earlier work from the same institute had already linked white matter hyperintensity burden in this population to age and to core Alzheimer's biomarkers, including beta-amyloid and phosphorylated tau. Those studies, though, were cross-sectional: each one captured a single moment in different people rather than following the same individuals as their brains changed.
That distinction is the point of the new analysis. As first author Alejandra Morcillo-Nieto of the Brain Imaging and Aging group at IR Sant Pau put it, cross-sectional work offers a snapshot of each stage, while this study allowed the team to watch the movie and confirm that the trajectory is not always linear.
For researchers, the implication is practical. If lesion volume can go down as well as up, treating white matter hyperintensities as a fixed tally of accumulated vascular damage risks misreading what a scan is showing, particularly in people who already have symptoms. That matters for how these markers are used to track disease progression and to judge whether an intervention is having an effect.